Another recent report demonstrated that MAEA can facilitate PHD3 ubiquitin-mediated degradation, ultimately favoring glioblastoma progression through enhanced stemness and the augmentation of temozolomide resistance 18. The gene discussed is EGLN3; the disease is glioblastoma.